drugset
drugset / Trial / NCT07247942

Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.

NCT07247942 ↗

Phase 1 Completed 8 enrolled Wockhardt Covance · collab
NaSingle-groupOpen-labelOther

Summary

A Phase 1, Open-label Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion in Healthy Male Subjects

Timeline

Start
2017-12-13
Primary completion
2018-01-20
Completion
2019-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Zidebactam Small molecule 1 g Intravenous

Indications

No indication recorded.